Peptonic wins arbitration case in China
Peptonic Medical AB (publ) today announced that an arbitration court in China has ruled in favor of Peptonic in a dispute with Yuanjia Biotechnology Co., Ltd.In November 2020 and February 2021, Peptonic Medical shipped goods to Yuanjia Bio in China for a total value of 406,000 EUR (approx. 4.4 MSEK). However, the goods were never paid for. As a result, Peptonic terminated the distribution agreement with Yuanjia Bio in August 2021 and filed an arbitration application against its former partner at a Chinese court. The court has now ruled in favor of Peptonic Medical and ordered Yuanjia Bio to